How do life sciences companies embed a lasting culture of continuous improvement instead of one-off flash-in-the-pan projects?

A continuous improvement program stands or falls not with the chosen method but with the sequence of its building blocks. First it needs a baseline: without a measured starting point, no success can later be demonstrated, and without demonstrated success the program loses the management commitment that ISO 13485:2016 requires anyway through the management review. Only then comes the system design with idea management, prioritization and performance measurement, and only last the individual Kaizen events. Anyone who starts with workshops before methodology, ownership and KPIs are in place creates isolated flashes in the pan instead of a sustainable structure.

The real hurdle in the regulated environment is the link to the change control system under the EU GMP Guide. Every process improvement affects validated states and requires impact assessment, QA approval and, where applicable, revalidation. When the CIP process is linked to change control from the outset, improvement runs in step with compliance; when it is routed around it, the fastest measure becomes the most expensive finding in the surveillance audit. This is precisely why we train internal multipliers instead of permanent dependence: an improvement culture is only sustainable if the organization carries it forward itself.